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In preliminary experiments, which wiU not be reported in detail, a 
considerable degree of immunity was produced in guinea pigs by re- 
peated injections with homologous tissue suspensions, in which the 
virus of lymphocytic choriomeningitis had been inactivated by the 
combined action of formalin and room temperature.  The immunity 
was incomplete in the majority of the cases, for the vaccinated guinea 
pigs showed fever, and sometimes slight symptoms after the test of 
immunity.  Virus could be  demonstrated in the  circulation during 
the febrile period. 
Vaccines prepared from the consolidated portions of the lungs of 
guinea pigs killed when moribund gave the most consistent results, 
while those made from other organs, for example, the brain and liver, 
often failed to produce immunity.  Since  the lungs of guinea pigs 
dying  of  choriomeningifis often  show  no  macroscopicaily  visible 
changes, and since vaccines prepared from relatively healthy parts of 
infected lungs appeared to be inferior, mixtures of several viscera, 
such as the lungs, brain, liver, spleen, kidneys, and suprarenals, were 
used for many vaccines, which usually gave good results.  Vaccines 
prepared from infected mouse tissue had very little immunizing  power 
for  guinea pigs,  even when  they were very rich in virus  prior  to 
formolization. 
The immunization of mice with formolized vaccines usually failed, 
no matter whether homologous or heterologous vaccines were used. 
In one experiment, however, a  certain degree of immunity was pro- 
duced in 9 out of 14 mice vaccinated by 3 intramuscular and intra- 
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peritoneal injections at 10 day intervals with a  vaccine prepared from 
the  brains, lungs,  livers, spleens, and kidneys of mice very sick from 
intravenous  injection  with  virus.  These  9  mice  developed  typical 
tremors and convulsions on the 6th or 7th day after the intracerebral 
test  injection  but  recovered,  while  14  control  mice  died  in  typical 
convulsions. 
The experiments to be reported here are concerned chiefly with the 
cause for the failure of heterologous vaccines to immunize guinea pigs, 
the  immunizing  power  of  homologous  vaccines  in  relation  to  their 
virus content prior to formolization, and the mechanism of the immu- 
nity produced in guinea pigs by inactive virus in comparison with that 
which follows an infection (1). 
Methods and Materials 
Preparation of Vaccines.--The  guinea pigs furnishing the tissue for vaccines 
were killed when very sick or moribund after pad or intracerebral injection with 
highly  virulent  guinea  pig passage virus  (1).  The  organs  used  were removed 
without  delay and ground very finely  in  a  tissue grinder.  Enough  saline was 
added to make a 20 per cent suspension  by weight.  In the earlier experiments 
the suspensions  were filtered through several layers of gauze,  but later the filtra- 
tion was omitted because it was found not to be necessary, provided the tissue 
was ground very finely.  In experiments in  which  the  tissue suspensions  were 
titrated a small portion of the suspension  was removed for this purpose soon after 
grinding.  To  the  remainder  of the  suspension  a  sufficient  amount  of  neutral 
formalin was added to make the final concentration of formalin 1 per cent (0.37 
per cent formaldehyde) by volume.  The vaccines contained in 50, 100, or 200 cc. 
Erlenmeyer flasks closed with rubber stoppers were vigorously shaken for a few 
minutes and then kept in a dark place in the laboratory for 2 days.  Thereafter 
they were stored in the refrigerator for the periods of time indicated below in the 
text.  The vaccine remaining after the removal of the amount needed for the first 
injection  was  transferred  to  test  tubes  and  covered with  vaseline until  used. 
Shortly before each injection the free formaldehyde in the vaccines was converted 
into urotropine by adding ammonium hydroxide until a  faintly pink color was 
obtained with phenolphthalein as indicator.  The colorimetric tests were carried 
out with a few drops of vaccine on a white porcelain plate commonly used for pH 
determinations according to  the indicator method.  The  "neutralized" vaccine 
was then injected immediately by the routes indicated in the text.  The majority 
of the guinea pigs to be vaccinated received 2 or 3 injections at 10 or 6 day inter- 
vals, because it had been found in previous experiments that repeated injections 
with vaccine usually conferred a stronger immunity than a single injection. 
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toxic peritonitis resulted from intraperitoneal injections.  Intramuscular  injec- 
tions were occasionally followed by a more or less marked induration at the site of 
inoculation.  The formalin in the concentration used appeared to have a strongly 
bactericidal action in the case of vaccines  prepared from diseased  lung,  which 
frequently contained  bacteria  that  were  harmful  when  the  suspensions  were 
injected without formalin. 
That the virus was completely inactivated in the vaccines is indicated by the 
fact that not one in over 200 guinea pigs injected developed evidence of infection. 
Furthermore, in many of the earlier experiments one or two extra guinea pigs 
were given excessively large doses of vaccine (0.2 cc. intracerebrally, 1 cc. in each 
hind pad, and 5 cc. intraperitoneally) without producing infection by such treat- 
ment.  These animals  were tested for circulating virus at different times after 
vaccination, with negative results in all cases. 
The strongest evidence for the  complete inactivation  of the  virus 
in the vaccines is the incomplete immunity produced by them in the 
majority of the guinea pigs, as will be shown later.  This low grade of 
immunity is in sharp contrast to the very solid resistance induced by 
small amounts of virus even in guinea pigs which failed to show fever 
after  the  immunizing  injection  (1). 
Two experiments were performed to determine the effect of the two 
inactivating  factors,  formalin  and  room  temperature,  on  the  virus. 
In both tests the formalin alone was  able  to inactivate  the virus in 
vaccines stored in the refrigerator for 9 days without previous incuba- 
tion at room temperature.  Storage for 2 days at room temperature 
without adding formalin to the vaccines inactivated the virus in  one 
test, but not in the other. 
Experimental Ani~nals.--The guinea pigs used weighed from 300 to 400 gm. in 
the majority of the  experiments and  were  obtained from the Institute  stock. 
The mice used for titrating tissue suspensions were 5 to 6 weeks of age and came 
from the Institute colony.  Both the guinea pig and mouse stocks are free from 
choriomeningitis.  Animals  used  in  experiments  on choriomeningitis  are  kept 
under isolation as a routine, and contact with infected animals is carefully avoided. 
Tea of Immunity.--A mixture of two highly virulent guinea pig passage strains 
(1) was used to test the immunity of vaccinated guinea pigs.  In the preliminary 
experiments control guinea  pigs occasionally  recovered from the severe disease 
induced by this virus.  Its virulence increased,  however,  on successive passages 
until it killed  all  the control animals  in  8 to  14 days after inoculation.  The 
standard dose for the tests of immunity was 0.5 cc. of a 1 per cent guinea pig brain 
suspension  injected  in  equal  parts  subcutaneously into  the  hind  pads.  This 
amount of suspension as a rule contained about 100,000 minimal infective doses of 
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Vaccination of Guinea Pigs with  Vaccines Prepared from Guinea Pig 
and Mouse Tissue 
To  confirm  the  results  of  the  preliminary  experiments,  in  which 
mouse tissue vaccines failed to immunize guinea pigs, while homologous 
vaccines produced immunity,  two other series of vaccines of guinea 
pig or mouse origin were tested. 
It proved difficult to obtain from each species vaccines  of about equal virus 
content, even when mixtures of several organs were used.  For this reason 10  -~ 
and 10  -2 dilutions of the vaccines were tested for immunizing  power besides the 
undiluted material.  Two mouse tissue  vaccines  (corresponding  to  guinea pig 
tissue  vaccines  7 and 8, Table I) had  to be discarded because  their virus con- 
tent was inferior. 
The vaccines with the corresponding numbers in Tables I and II were prepared, 
titrated, and injected at the same time, and the guinea pigs inoculated with them 
were tested for immunity with  the same materials.  Before formolization the 
tissue suspensions were titrated in guinea pigs by pad injection with 1 cc. of the 
decimal dilutions in saline of the vaccines, one animal being used for each dilution. 
The vaccines were stored at room temperature for 2 days and in the refrigerator 
for 8 days.  The guinea pigs to be vaccinated were injected twice at an interval 
of 10 days with 1 cc. into each thigh and 2 cc. intraperitoneaUy, making a total of 
8 cc. vaccine per guinea pig,  Their immunity was tested 2 weeks after the second 
vaccination. 
The  summary  of  the  results  in  Tables  I  and  II  shows  that  the 
undiluted guinea pig tissue vaccines produced immunity in every case 
and that some vaccines were also effective in a  10  -~ dilution, whereas 
the  vaccines prepared from mouse  tissue,  with  one exception,  com- 
pletely  failed  to  immunize,  even  when  their  virus  content  before 
formolization was very high. 
A  comparison of the virus content of the guinea pig vaccines before 
formollzation with their immunizing power suggests a lack of parallel- 
ism between the two factors.  The result  obtained  with  guinea  pig 
tissue vaccine 7 points in the same direction.  In this case the tissue 
suspension was divided into two parts before formolization.  One part 
was used as a  whole, while the other part was  centrifuged at 1600 to 
1700 R.p.x~. for 10  minutes.  Vaccines were prepared from the whole 
suspension as well as from the supernatant fluid.  In spite of the fact 
that  both materials  gave  the  same  titration  end-point,  the  vaccine ERICH  TRAUB 
TABLE  I 
Vaccination  of Guinea Pigs witk Vaccines Prepared from Guinea Pig Tissue 
99 
No. 
Reaction to test of immunity of guinea 
Vaccine  pigs vaccinated with different 
remounts of vaccine 
Dilution in saline of vaccine 
Tissue constituents  Titer 
Brain, lung, spleen  100Tq-* 
......  lO--S 
Brain, lung, liver, spleen  10  ~ 
Lung  10  ~ 
Lung,  spleen,  suprarenal  I0-7q- 
Lung, liver, spleen, suprarenal  10  °7 
Brain, lung, liver, spleen 
Brain,  lung,  heart,  liver,  spleen, 
kidney, suprarcnal: 
10-7 
10o 
q- 
o 
o 
q- 
q- 
q- 
q- 
q- 
+ 
q- 
q- 
q- 
q-q- 
Whole suspension  10  s  q- 
q-q- 
Supernatant of  same suspension  I0  -s  q-q-q- 
q-q-q-q- 
t0-x 
+ 
++ 
++++ 
+ 
++++ 
++ 
++++ 
++++ 
++++ 
++++ 
++++ 
10"t 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
In this and the following tables: 
0  ffi no detectable reaction to the test inoculation. 
-{-  ffi fever, but no other signs of illness. 
q- q-  ffi fever,  slight symptoms and a  slight loss of weight, followed by 
rapid recovery. 
-{-q-q-  =  fever, severe symptoms with marked loss of weight, followed by 
slow recovery. 
q- -{--{-  -t-  ffi died of choriomeningitis. 
* The q- sign indicates that the titration end-point was perhaps not reached at 
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made from the whole suspension had a greater immunizing power than 
that from the supernatant liquid. 
Inhibition  of  the  Immunity  by  Injecting  Formolized  Normal  Mouse 
Tissue Together with the Guinea Pig Tissue Vaccines 
The following experiments were performed in an attempt to deter- 
mine  the cause for the failure of heterologous vaccines to immunize 
TABLE  II 
Vaccination of Guinea Pigs with Vaccines Prepared  from Mouse Tissue 
No. 
1 
2 
3 
Vaccine 
Tissue constituents  Titer 
Brain, lung, spleen  10  -s 
.  .  ,,  10-6 
Brain, lung, liver, spleen  t0-  6 
Brain, liver, spleen  10-Tq  - 
Embryos from an infected pregnant mouse  10-7+ 
Brain, lung, liver, spleen  10-e 
Reaction to test of immunity 
of guinea pigs vaccinated with 
diiterent amounts of vaccine 
Dilution in saline of vaccine 
1~  lO-1 
++++ 
++++ 
++++  ++++ 
++++ 
++++*  ++++ 
++++ 
++  ++++ 
++++ 
++++ 
++++ 
++++ 
* This animal received 3 injections with vaccine at 10 day intervals and was 
tested for immunity 14 days after the 3rd injection. 
guinea pigs.  Laidlaw and Dunkin  (2) also failed with dog distemper 
and  attributed  the  phenomenon  to  the  clogging  of  the  immunity 
mechanism by heterologous antigens.  This appeared to be a  reason- 
able explanation, but direct experimental evidence for it was lacking. 
It was therefore decided to add formolized normal mouse tissue to the 
guinea pig tissue vaccines or to inject it simultaneously with them, in 
order to determine its effect on their immunizing power. ERICH  TRAUB  101 
In the experiments of the first series (Table III) the vaccines and the formolized 
normal mouse tissue suspensions were mixed (2 parts to 1) shortly before inocula- 
tion.  One group of guinea pigs received the tissue mixture, and another group 
the vaccine mixed with a corresponding amount of saline.  In the experiments of 
the second series (Table IV) the vaccine and the normal mouse tissue were injected 
TABLE  III 
Inhibition of Immunity by Heterologous Antigens 
Vaccines from Guinea Pig Tissue and Formolized Normal Mouse Tissue Mixed 
before Injection 
No. 
Lung 
Tissue constituents 
Vaccine  Reaction to test of immunity 
Lung,  liver,  spleen~ 
suprarenals, severa] 
lymph nodes 
Brain,  lung,  spleen, 
suprarenals, liver 
Lung 
Brain 
Dose of mixtures and 
route of inoculation 
2 X 3 cc.  ira*  (thighs) 
at I0  day interval 
2 × 3 cc.  im (thighs) 
+  3  cc.  ip  at  I0  day 
interval 
2  X  3 cc. ip at 6 day 
interval 
3  X  3 cc. ip at 6 day 
intervals 
Guinea pigs 
injected with 
vaccine + 
saline 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
++ 
+ 
++ 
+ 
+ 
++++ 
G~nea p~s 
injected with 
v~ne  +  Unvacdnated 
formofi~d  ~ntrols 
nor~  mou~ 
~ue 
+  ++++ 
+  ++++ 
++  ++++ 
++++  ++++ 
+++  ++++ 
++++  ++++ 
++++  ++++ 
+  ++++ 
++++  ++++ 
++++  ++++ 
++++  ++++ 
++++  ++++ 
++++  ++++ 
++++  ++++ 
* im  =  intramuscularly; ip =  intraperitoneally. 
either by different routes (vaccine 5) or by the same route but on opposite sides 
of the body (vaccines 6 to 11).  Saline inoculations were omitted. 
The vaccines and the corresponding suspensions of normal mouse tissue pre- 
pared from the same organs and in the same manner as the vaccines were kept at 
room temperature for 2  days and in the refrigerator for 7  to  14  days prior to 
injection.  Ammonium  hydroxide was  added  to  the  mouse  tissue  suspensions 
in the same manner as to the vaccines before the materials were mixed, and the 
mixtures were inoculated a  few minutes after mixing.  The  tissue constituents, 102  IMMUNITY  TO  LYMPHOCYTIC CHORIOMEN1NGITIS 
TABLE  IV 
Inhibition of Immunity by Iteterologous Antigens 
Vaccines from Guinea Pig Tissue and Formolized Normal Mouse Tissue Injected 
Simultaneously but by Different Routes 
Vaccine  Reaction to  test  of  immunity 
No. 
10 
II 
Dosage  and routes  of  inoculation 
3 X  2 cc. vaccine ip* +  0.5 cc. 
f.n.m.t.~  in  each thigh  at 6 day 
intervals 
2 X  Icc. im (thigh)  +  Icc. sc 
(flank)  at  I0  day  interval. Vac- 
cine  injected  on  left  side  of  body, 
an equal amount of f.n.m.t,  on 
right  side 
I X  I cc.  im (thigh)  +  Icc. im 
(back) +  Icc. sc (hind  pad). 
Vaccine injected on left  side, 
f.n.m.t,  on right  side 
~nvaccinated 
controls 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
++++ 
* ip  =  intraperitoneally; im  =  intramuscularly; sc  ==  subcutaneously. 
t  f.n.m.t,  ffi formolized normal mouse tissue. ERICH TRAY3  103 
the dosage, and the routes of inoculation are indicated in the tables.  The guinea 
pigs were tested for immunity  in the usual manner  2 to 3 weeks after the last 
injection of vaccine. 
The  results presented  in  Tables III and  IV show that  the heter- 
ologous normal tissue inhibited the immunity in a  certain number of 
cases.  The  inhibitory  effect was generally  more  marked  when  the 
materials were mixed before injection than when they were inoculated 
simultaneously on opposite sides of the body.  In the one comparative 
experiment  (vaccine  5)  the  same  result  was  obtained  with  both 
methods.  As  in  previous  tests,  lung  vaccines  proved  superior  to 
vaccines prepared from brain or liver. 
The Immunizing  Power of Guinea Pig Tissue Vaccines in Relation to 
Their Virus Content before Formolisation 
Since the results of the experiments recorded in Table I  suggested a 
lack  of parallelism  between the  virus  content  of vaccines prepared 
from  guinea  pig  tissues  and  their  immunizing  properties,  another 
series of similar  experiments was carried out, in which the titration 
end-points of the suspensions used for vaccines were more accurately 
determined.  In  order  to  eliminate  any  interference  by bacterial 
antigens,  lung vaccines were not  used and  the  tissues  selected were 
free from cultivable organisms. 
The  tissue  suspensions from  which the  vaccines were  made  were  titrated 
immediately after grinding by intracerebral injection of mice with 0.05 ×  10  -a 
to 0.05 ×  10  -7 cc., 3 mice being used for each dilution in saline.  The vaccines 
were formolized as usual and stored for 2 days at room temperature and for 7 clays 
in the refrigerator.  Guinea  pigs were vaccinated by 3 intraperitoneal injections 
at 6 day intervals with 2 cc. undiluted or diluted vaccine, as indicated in Table V, 
and tested for ~mmunity 15 days after the last vaccination. 
The results recorded in Table V show that the immunizing power of 
the  vaccines  did  not  parallel  their  content  of active virus prior  to 
formolization.  In  the  first  experiment,  3  vaccines  prepared  from 
different tissues of the same animals  were compared.  The vaccines 
prepared from the liver, heart,  and spleen tissue were inferior to the 
brain vaccine in spite of the fact that the heart and spleen suspensions 
probably contained  as much virus as the  brain  suspension  and  the 104  ~3/UNITY  TO  LYMPHOCYTIC  CHORIOMENINGITIS 
TABLE  V 
Immunizing Power of Guinea Pig  Tissue  Vaccines in Relation  to  Virus  Content 
Prior to Formolization 
Stage of disease at which 
tissue was removed from 
guinea pig 
12th day after pad in- 
jection when mori- 
bund 
llth day after pad in- 
jection  when  very 
sick 
6th day after ic injec- 
tion (high fever) 
9th day after ic injec- 
tion when moribund 
4th day after ic injec- 
tion  (moderate 
fever) 
Titration by iet 
mouse injection prior 
to formolization 
Reaction to test of immunity of 
guinea pigs vaccinated with 
different amounts of vaccine 
T)ilutlon ;n -~]ine nf  vaccine 
10-2 
10  -4  D  D  D 
10  -5  D  D  --  q--t-++ 
10  4  D  D  --  -b+-t--I- 
10-7 
10  -4  D  D  D 
10  -5  D  ----  +q-q-+ 
I0  -~  D  ----  ++++ 
10-7 
10  -5  D  D  D 
10  .5  D  D  D  ++++ 
lo~  ++++ 
10-7 
10-*  D  D  D 
10  -5  D  D  D  +q'++ 
10-6  ++++ 
10-7 
I0  -~  D  D  .D 
10  -5  D  D  D  -t-+++ 
10  -6  D  ----  q'+++ 
10-7 
10  -4  D  D  D 
10  -5  D  D-  ++++ 
lO-e  ++++ 
10-  ~ 
10  -4  D  D  D 
I0  -s  D  D  D  ++++ 
I0  -~  D  D  --  ++++ 
10-7 
* Each vaccine was prepared from respective organs of 2 guinea pigs. 
tic  =  intracerebrally. 
D  ,= mouse died, or was killed in typical convulsions. 
:~ This guinea pig died from toxic peritonitis I day after the 1st vaccine injection. ~.~CH  TI~AUB  105 
liver  suspension  contained more.  Since  the  results  obtained  with 
these three vaccines may not be strictly comparable because of their 
different tissue constituents, the vaccines in the following experiments 
were  all  prepared  from brain.  A  comparison  of their  immunizing 
properties shows clearly that  they did not  correspond to  the virus 
content of the suspensions.  This was particularly striking in the 3rd 
experiment, in which the vaccine prepared from brain removed during 
the earlier stage of the disease was richer in virus but poorer in immun- 
izing  substance  than  the  vaccine  made  from  brain  obtained  from 
moribund  animals. 
Experiments  Bearing on the Mechanism  of the Immunity  Induced  by 
Formolized Tissue Vaccines 
The following experiments were undertaken in an attempt to deter- 
mine  first,  whether  prolonged  treatment  with  large  amounts  of 
homologous vaccine would lead to  a  high degree of immunity and, 
second, whether protective serum antibodies could be produced by 
such treatment.  In previous tests the sera of guinea pigs vaccinated 
in the usual manner (by 2 or 3 vaccine injections) failed to have any 
neutralizing effect on the virus, although the guinea pigs were immune. 
Sera drawn on the 10th day after the test of immunity as a rule had 
protective properties.  In 2 out of 10 such sera virus and antibodies 
were present at the same time, that is, the sera were virulent on intra- 
cerebral inoculation but failed to infect, and even neutralized about 
10 a*.I.D, of virus added to them, when injected into the pads.  This 
rather rapid appearance of the antibodies is in contrast to the relatively 
slow formation of antivirus in unvaccinated guinea pigs after injection 
with virus (1).  Their serum usually contained no demonstrable anti- 
body on the 10th day after inoculation.  It is possible, therefore, that 
the vaccination causes the production of a very small amount of anti- 
body not demonstrable by the usual neutralization test, and that the 
antibody production is enhanced by inoculation with active virus. 
The vaccines used for the "hyperimmunization" of guinea pigs were prepared 
from the lungs, liver, brain, heart, spleen, kidneys, or suprarenals of guinea pigs 
moribund after pad injection with  virus.  The suprarenal vaccines were 10 per 
cent suspensions by weight, while all the other vaccines were  20 per cent suspen- 
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the refrigerator for 7 to 14 days.  Guinea pigs weighing from 500 to 600 gin. were 
given alternating intraperitoneal,  intramuscular, and subcutaneous injections at 
5 to 7 day intervals with varying large doses depending on the amount of vaccine 
available at  the  time of  inoculation.  The number of injections  and the total 
amount of vaccine given are recorded in Table VI.  The immunity was tested as 
usual on the 17th day after the last vaccination.  2 days before the test of im- 
munity 10 cc. of heart blood were taken from each animal in order to obtain serum 
for protection tests. 
TABLE  VI 
Hyperiramunizagon of Guinea Pigs with Vaccines Prepared  from Guinea Pig Tissue 
Tissue from  which 
acclne was prepared 
Lung 
Liver 
Brain 
Heart 
Spleen 
Kidney 
Suprarensl 
Guinea pig 
No. 
1 
2 
3 
4 
5 
6 
7 
8 
9 
Number of 
injections at 
5 to 7 day 
intervals 
Total 
amount  of 
vaccine given 
¢£.. 
32 
30.5 
34.5 
34.5 
39.5 
33.5 
34 
33 
29.5 
g 
°~ 
o 
t~ 
Reaction to test of immu- 
nity by pad injection with 
106 to 10' M.X,D. of virus 
V~d  Unv~dna~d 
~inea pigs  consols 
o  ++++ 
o  ++++ 
+  ++++ 
0  ++++ 
+  ++++ 
0  ]++++ 
! 
i  +  !++++ 
+  ++++ 
+  ++++ 
Table VI shows that 4  of the 9  guinea pigs vaccinated became so 
highly immune that they showed no reaction  to the  test inoculation 
which was fatal in all 9  controls.  The degree of immunity in these 4 
animals,  therefore,  compares favorably with that of guinea pigs that 
have gone through  an infection  (1). 
The  remaining guinea pigs  showed a  moderate  fever which  was  of shorter 
duration  than  in  guinea  pigs  vaccinated  in  the  ordinary manner.  There was 
practically no loss of weight or condition in all the animals.  Some of the guinea 
pigs that  showed fever carried  traces  of  virus in  the blood during the febrile z~ca  r~UB  107 
period, while in the 4 guinea pigs without reaction no circulating virus was detected 
on the 6th and 8th days after  the test of immunity.  The tests  for virus were 
made by injecting normal guinea pigs  intracerebrally with 0.25  cc. heart blood 
of the vaccinated animals. 
The sera obtained from the 9 guinea  pigs were pooled, and the mixture was 
tested for protective antibodies by  neutralization and protection tests in guinea 
pigs.  In the neutralization tests the mixtures of serum (0.25 cc.) and virus (0.25 
cc.) incubated  for ~  hour  at  room temperature  were injected  into the pads of 
guinea pigs as described before (3).  The results of the tests presented in Table 
VII show that the immune serum neutralized approximately one minimal lethal 
dose (~.L.D.) of virus. 
TABLE  VII 
Neutralization Tests ~ith Serum from Guinea Pigs Hyperimmunized with 
Formoli~d Vaccines 
Test No.  Serum from 
Results of pad injections in guinea pigs with mixtures 
of serum and virus 
Dilutions of supernatant of virulent 10 per cent 
guinea pig brain suspension 
9 vaccinated guinea pigs  D  S  S 
Normal guinea pigs  D  D  S 
9 vaccinated guinea pigs  D  D  S 
Normal guinea pigs  D  D  S 
* D  ffi the guinea pig died of choriomeningitis. 
S  ffi the guinea pig survived, showed no signs of illness,  and was not immune 
to reinoculation with virus. 
The first protection test in which 2 guinea pigs weighing 450 to 500 gm. received 
1 cc. of  the  pooled immune  serum intravenously  ~  hour  before pad  injection 
with 1 to 10 M.L.V. of virus gave a negative result.  The test was therefore repeated 
using larger amounts of serum.  A guinea pig was given 3 cc. serum intravenously 
½  hour  before a  similar virus inoculation, and  4 cc. by the same route 5 days 
l~ter.  The  animal  developed  comparatively  mild,  non-fatal  choriomeningitis, 
while the 2 control animals not treated with serum died.  In the next experiment 
still larger amounts of serum were used.  Two guinea pigs received 5 cc. immune 
serum  intravenously  2  hours  before pad  inoculation  with  about  105  g.L.V,  of 
virus, 5 cc. serum intravenously on the 5th day, and 4 cc. intracardiallyon the 
8th day after the virus inoculation.  One of these 2 animals showed fever, but no 
other definite signs of illness,  while the other  developed  mild  choriomeningitis 
followed by quick recovery.  The 2 untreated controls died of choriomeningitis. 108  IMMUNITY  TO  LYMPHOCYTIC  CHORIOMENINGITIS 
These tests indicate that the formolized vaccines, when administered 
in large amounts, can give rise to protective antibodies, whose concen- 
tration, however, is rather low in view of the considerable degree of 
immunity acquired by the donor animals. 
DISCUSSION 
The vaccines used in the experiments reported are considered to 
contain completely inactive virus because of the rigorous treatment 
given  to  them,  the  consistent  absence of  symptoms in vaccinated 
animals,  and  the  failure  to  detect  circulating virus  in  vaccinated 
guinea pigs.  It  is possible  that  a  lower concentration of formalin 
would have sufficed  to inactivate the virus and permitted the pro- 
duction of more effective vaccines, but in such a case one could not be 
certain that one was always dealing with a completely inactive agent. 
The degree of immunity produced by the vaccines used is far inferior 
to that induced by modified active virus (1), which immunizes guinea 
pigs solidly even in cases in which they show no detectable reaction 
to the virus inoculation. 
The inhibition of the immunity by adding formolized normal mouse 
tissue  to  the guinea pig tissue vaccines supports  the suggestion of 
Laidlaw and Dunkin (2) that the failure of heterologous vaccines to 
immunize is  due  to  the  clogging of  the  immunity mechanism by 
heterologous  antigens.  Since  the  ingredients  were  treated  alike 
before mixing, it is unlikely that the decrease in immunizing power in 
the mixtures was  caused by chemical reactions between their  con- 
stituents, altering the antigenic properties of the vaccines.  The fact 
that the inhibition of the immunity was more pronounced when the 
materials were mixed before inoculation than when they were injected 
simultaneously on  opposite sides of  the body can be  explained by 
assuming that the clogging process is mainly a  mechanical phenom- 
enon, which is most marked when the different antigens reach the same 
receptive tissues at the same time. 
The lack of parallelism between the virus content of homologous 
vaccines prior to formolization and their immunizing power cannot be 
satisfactorily explained.  One might assume either that compounds 
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infected tissues, or that non-infectious split products of the virus take 
part in the  immunization. 
In view of the high degree of immunity and the protective antibodies 
produced  by  prolonged  treatment  with  large  doses  of  formolized 
vaccine there is at present no good reason to suppose that the mecha- 
nism of the immunity induced by inactive virus differs fundamentally 
from that of the immunity which follows an infection.  The differ- 
ences seem to be quantitative rather than qualitative. 
SI)~MARY 
Guinea  pigs  can  be  immunized against  lymphocytic choHomeningitis 
by 2 or 3 injections  with formolized  vaccines  prepared from a variety 
of infected  guinca pig tissues. Vaccines prepared from the consoll- 
dated areas  of diseased  lungs gave the best  results. The immunity 
produced was partial  in the majority of the cases,  in that the vacci- 
nated animals as a rule  showed fever  after  the test  of immunity and 
virus  was  present  in  the  circulation  during the  febrile  period. 
Vaccines prepared from infected  mouse tissue  had no, or  very  little, 
immunizing power for guinea pigs,  even when prior to formolization 
they contained at least  as much virus  as guinea pig tissue  vaccines. 
This failure  to immunize appears to be due to the interference  by 
heterologous antigens,  since the immunity induced by homologous 
vaccines was often inhibited  when formolized normal mouse tissue 
suspensions treated  in the same manner as the guinea  pig tissue 
vaccines  were added to the latter  before  inoculation. The inhibitory 
effect  of  the  heterologous  tissue  was  less  marked when it  was not  mixed 
with the vaccine but injected  simultaneously on the opposite side  of 
the body. 
The immunizing power of homologous vaccines did not parallcl 
their  virus  content  prior  to  formolization. 
A high degree of immunity, characterized  by protective  antibodies 
in the serum, was produced in some guinea pigs  by prolonged treat- 
ment with large doses  of homologous vaccine, while sera  of guinea 
pigs vaccinated in the ordinary manner  contained no detectable 
neutralizing  antibodies.  It is  possible,  therefore,  that the immunity 110  TMMUNITY TO  LYMPHOCYTIC CHORIOMENINGITIS 
produced  by  inactive  virus  differs  only  quantitatively from  that 
induced  by an infection. 
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